This trial is active, not recruiting.

Condition hiv infections
Treatment stage based counseling
Sponsor Johns Hopkins University
Collaborator University of California, San Francisco
Start date September 2003
End date October 2007
Trial size 425 participants
Trial identifier NCT00538993, H97HA01144


Hypothesis: HIV clinicians trained to deliver brief counseling messages and receiving cues from a brief computer survey on risk behaviors of their patients can counsel have an impact on patient's risk behaviors.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose health services research
Provider receives cue sheet to assist with counseling.
stage based counseling
(No Intervention)
Provider does not receive cue sheet.

Primary Outcomes

Disclosure of HIV status to sex partners; unprotected sexual encounters.
time frame: 12 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - HIV seropositive - English speaking Exclusion Criteria: - Cannot give informed consent

Additional Information

Principal investigator Emily Erbelding, M.D.
Description This is a randomized controlled study. The purpose of this study is to assess the impact of the cue sheet as an aid to targeted provider behavioral counseling. All enrolled participants are HIV+ adults seen for regular medical care at a site affiliated with the Johns Hopkins AIDS Service. After consenting, participants will take an audio-assisted computer interviews to collect patient risk assessment data. For participants randomized to the intervention arm, the printed output on risk behaviors is then given to the provider along with cues for staged-based counseling for use during the same visit. Participants in the control arm take the same computerized risk assessment but there are no printed cue sheets. Risk behaviors of all participants are assessed at entry, at 6 months, and at 12 months. The main outcome measure is change in HIV transmission behaviors at 12 months for those in the intervention arm compared to the control arm.
Trial information was received from ClinicalTrials.gov and was last updated in October 2007.
Information provided to ClinicalTrials.gov by Johns Hopkins University.